University of Colorado Boulder 1002174454

PHH3 (polyclonal) PAb, Cell Marque; CONFIRM MART-1/melan A (A103) Primary An; ANTI-P53 (Bp53-11) PaB; VENTANA ANTI-P6...

This order from the University of Colorado Boulder, a public college or university in Colorado, USA, awards Roche Diagnostics Corporation a purchase contract dated August 11, 2025. The order includes laboratory reagents and antibodies, such as PHH3 (polyclonal) PAb, confirmatory MART-1/melan A primary antibody, anti-P53 antibody, Ventana anti-P63 antibody, and CD117 rabbit monoclonal PAB, totaling approximately $2,378.14 across 5 line items with specified unit prices and quantities. The contract appears to cover a one-time procurement of laboratory supplies for the university's Department of SOM-DERM CLINICAL. No special contract requirements are noted.

Description

PHH3 (polyclonal) PAb, Cell Marque; CONFIRM MART-1/melan A (A103) Primary An; ANTI-P53 (Bp53-11) PaB; VENTANA ANTI-P63 (4A4); CD117(EP10) Rabbit Monoclonal PAB